2021
DOI: 10.1016/j.beem.2021.101487
|View full text |Cite
|
Sign up to set email alerts
|

Medical therapy in severe hypercortisolism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 35 publications
2
5
0
Order By: Relevance
“…The antifungal drug, ketoconazole, is a glucocorticoid receptor antagonist, which can inhibit the biosynthesis of the adrenal gland and reduce the level of endogenous cortisol. 31 In a retrospective cohort study with a total of 41 naive CSC eyes, it was found that ketoconazole treatment could shorten the disease duration through promoting SRF absorbtion. 32 Another effective glucocorticoid antagonist, mifepristone, was used in CSC treatment.…”
Section: Discussionmentioning
confidence: 99%
“…The antifungal drug, ketoconazole, is a glucocorticoid receptor antagonist, which can inhibit the biosynthesis of the adrenal gland and reduce the level of endogenous cortisol. 31 In a retrospective cohort study with a total of 41 naive CSC eyes, it was found that ketoconazole treatment could shorten the disease duration through promoting SRF absorbtion. 32 Another effective glucocorticoid antagonist, mifepristone, was used in CSC treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Multiple serial tests of both UFC and LNSC are used to monitor treatment outcomes. 158,232,233 A brief summary of Workshop discussions about how to best incorporate each of the different treatment options is presented below and in Panel 2.…”
Section: Medical Therapy: Clinical Considerations and Recommendationsmentioning
confidence: 99%
“…A glucocorticoid receptor antagonist, mifepristone, has a rapid action as well, but its use has been limited because of difficulties in monitoring its efficacy and safety. Other slow-acting cortisol-lowering medications (mitotane, cabergoline, and pasireotide) might be candidates in the therapeutic options [ 30 ].…”
Section: Discussionmentioning
confidence: 99%